课题基金 / 基金详情

Molecular requirements for proliferation of fetal and adult liver progenitors

Molecular requirements for proliferation of fetal and adult liver progenitors
胎儿和成人肝脏祖细胞增殖的分子需求
批准号:
8549380
负责人:
Stacey S Huppert
金额:
$23.5万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-07 至 2014-06-30

项目摘要

项目成果

Stacey S Huppert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Both ligand and receptors of the Notch pathway have been identified as the causitive factors in Allagille syndrome, a complex developmental disorder. A distinguishing characteristic of this syndrome is cholestasis brought on by paucity of bile ducts. Notch signaling, in general, is a critical molecular component for lineage commitment decisions that affect cell maturation relative to neighboring cells. Thus, we hypothesize that Notch signaling during hepatic morphogenesis and/or regeneration controls the lineage commitment and/or cell fate decisions of progenitor cells that underlie formation of the hepatic biliary and vascular architecture. Formation of this architecture is vitally important for normal hepatic function. Thus, the overall goal of this proposal is to identify and define the cell lineages that require Notch signaling for formation of the hepatic architecture, both during normal hepatic morphogenesis and during regeneration in the adult. Two specific aims are proposed. In Aim 1 we will identify and trace the lineage of cells that activate Notch1 during development and adult liver regeneration. In Aim 2 we will determine whether the Notch pathway plays a direct or indirect role in the proliferation and morphogenesis of the hepatoblast progenitor cell population using mouse models generated to specifically delete Notch signaling in the endoderm and endothelial cell lineages. Both Aims will be achieved by taking advantage of pre-existing mouse models that enable lineage tracing and the lineage- specific ablation of Notch signaling. These studies are significant in that they will define the key site(s) of Notch activation during both the development of the liver and its regeneration in adult populations. The knowledge we gain may, in time, enhance our ability to treat chronic liver diseases, which are currently the 7th leading cause of death in the United States.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
A faithful JAGGED1 haploinsufficiency mouse model of arteriohepatic dysplasia (Alagille syndrome) after all.
毕竟是忠实的 JAGGED1 单倍体不足小鼠模型,是动脉肝发育不良(Alagille 综合征)的模型。
DOI: 10.1002/hep.28338
发表时间: 2016
期刊: Hepatology (Baltimore, Md.)
影响因子: --
作者: [Huppert,StaceyS]
通讯作者: Huppert,StaceyS
DOI: 10.1242/dmm.005793
发表时间: 2011-05
期刊: Disease models & mechanisms
影响因子: 4.3
作者: [Sparks EE, Perrien DS, Huppert KA, Peterson TE, Huppert SS]
通讯作者: Huppert SS
DOI: 10.1002/hep.23431
发表时间: 2010-04
期刊: HEPATOLOGY
影响因子: 13.5
作者: [Sparks, Erin E., Huppert, Kari A., Brown, Melanie A., Washington, M. Kay, Huppert, Stacey S.]
通讯作者: Huppert, Stacey S.
DOI: 10.1097/mot.0000000000000365
发表时间: 2016-12
期刊: Current opinion in organ transplantation
影响因子: 2.2
作者: [Huppert SS, Campbell KM]
通讯作者: Campbell KM
Alagille Syndrome Scientific Meeting - Measuring What Matters
Targeting POGLUT1 to promote biliary development in Alagille syndrome
  • 批准号:
    10449607
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2022
  • 负责人:
    Stacey S Huppert
  • 依托单位:
Molecular regulation of hepatic cell differentiation and maturation
  • 批准号:
    10456054
  • 项目类别:
  • 资助金额:
    $40.28万
  • 财政年份:
    2019
  • 负责人:
    Stacey S Huppert
  • 依托单位:
Molecular regulation of hepatic cell differentiation and maturation
  • 批准号:
    10022327
  • 项目类别:
  • 资助金额:
    $40.28万
  • 财政年份:
    2019
  • 负责人:
    Stacey S Huppert
  • 依托单位:
海外基金